Target
Stanniocalcin-1
Ligand
BDBM50579519
Substrate
n/a
Meas. Tech.
ChEMBL_2135458 (CHEMBL4845068)
IC50
33±n/a nM
Citation
 Turdi, HChao, HHangeland, JJAhmad, SMeng, WBrigance, RZhao, GWang, WMoore, FYe, XYMathur, AHou, XKempson, JWu, DRLi, YXAzzara, AVMa, ZChu, CHChen, LCullen, MJRooney, SHarvey, SKopcho, LPanemangelor, RAbell, LO'Malley, KKeim, WJDierks, EChang, SFoster, KApedo, AHarden, DDabros, MGao, QPelleymounter, MAWhaley, JMRobl, JACheng, DLawrence, RMDevasthale, P Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders. J Med Chem 64:14773-14792 (2021) [PubMed]  Article 
Target
Name:
Stanniocalcin-1
Synonyms:
STC | STC-1 | STC1 | STC1_HUMAN | Stanniocalcin-1
Type:
PROTEIN
Mol. Mass.:
27627.69
Organism:
Homo sapiens
Description:
ChEMBL_120405
Residue:
247
Sequence:
MLQNSAVLLVLVISASATHEAEQNDSVSPRKSRVAAQNSAEVVRCLNSALQVGCGAFACLENSTCDTDGMYDICKSFLYSAAKFDTQGKAFVKESLKCIANGVTSKVFLAIRRCSTFQRMIAEVQEECYSKLNVCSIAKRNPEAITEVVQLPNHFSNRYYNRLVRSLLECDEDTVSTIRDSLMEKIGPNMASLFHILQTDHCAQTHPRADFNRRRTNEPQKLKVLLRNLRGEEDSPSHIKRTSHESA
  
Inhibitor
Name:
BDBM50579519
Synonyms:
CHEMBL3912712
Type:
Small organic molecule
Emp. Form.:
C24H21F6N5O2
Mol. Mass.:
525.4463
SMILES:
Cc1ccc(cc1)C1=C(c2nn[nH]n2)C(O)=N[C@@](C1)(c1ccc(OCCCC(F)(F)F)cc1)C(F)(F)F |r,c:8,17|
Structure:
Search PDB for entries with ligand similarity: